Radiologic Findings of Mesothelioma at the Tunica Vaginalis

Soonchunhyang University, Onyang, Chungcheongnam-do, South Korea
Urology (Impact Factor: 2.19). 05/2012; 80(1):e3-5. DOI: 10.1016/j.urology.2012.02.050
Source: PubMed


Malignant mesothelioma of the tunica vaginalis testis is a rare, but often fatal, malignancy that usually appears during the fourth decade and has a strong relationship with occupational exposure to asbestos and long-lasting hydrocele. We present a case involving a 36-year-old man without a history of hydrocele, trauma, or exposure to asbestos who developed malignant mesothelioma.

10 Reads

  • Journal of Clinical Urology 03/2013; 8(2). DOI:10.1177/2051415813511082
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hydrocelectomy and spermatocelectomy are routine scrotal surgeries. A significant number of the surgical specimens are sent for pathological analysis. However, no analysis has been done to examine outcomes and necessity. This results in significant potentially unnecessary costs to both the patient and the health care system. We evaluated the outcomes and the surgical pathological analysis of hydroceles and spermatoceles. We performed a single-institution retrospective chart review of all patients who underwent their first surgery for hydrocele or spermatocele between January 2000 and August 2013. We determined the number of cases in which a surgical specimen was sent for pathological exam. The cost for each specimen was estimated by our Department of Pathology. A total of 264 routine scrotal cases were performed over the 14-year period. Surgical specimens were sent for pathologic analysis in 51% (n=102) of hydrocelectomy cases and in more than 90% (n=57) of spermatocelectomies. Of the pathologic specimens obtained, none showed any indications of malignancy. The estimated direct total cost for pathologic analysis amounted to $49,449 for this cohort. As no malignancies were detected in 159 hydrocele and spermatocele specimens over the 14 years of this study, it suggests that the pathologic analysis is of little clinical benefit. Forgoing surgical pathologic analysis of these specimens would result in a significant cost savings to both the patient and the health care system.
    The Journal of urology 04/2014; 192(4). DOI:10.1016/j.juro.2014.04.085 · 4.47 Impact Factor

Similar Publications